Latest News about Teva
Recent news which mentions Teva
Nasdaq, S&P 500 Futures Slip Ahead Of Inflation Data — But Analyst Hints It Still Might Be Ok To Be Bullish
May 10, 2023
From Benzinga
From Benzinga
From Benzinga
Why this might be a good time to buy junk bonds
April 27, 2023
From MarketWatch
10 Health Care Stocks With Whale Alerts In Today's Session
April 19, 2023
From Benzinga
1 "Safe" Stock to Avoid and 1 to Consider Buying in April
April 15, 2023
From Motley Fool
Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 14, 2023
From Benzinga
Boeing, Spirit AeroSystems And Other Big Stocks Moving Lower In Friday's Pre-Market Session
April 14, 2023
From Benzinga
Emergent BioSolutions Soars: Analyst Upgrades Stock With Near 100% Upside After FDA's Positive Move
April 10, 2023
From Benzinga
7 A-Rated Stocks to Buy for April 2023
April 07, 2023
From InvestorPlace
Stage Set For Generics As Biden Admin Asks Supreme Court To Hear Skinny Labels Case Between GSK, Teva
March 31, 2023
From Benzinga
Amid Adderall shortage, CDC says pandemic may have ‘led to or exacerbated’ ADHD symptoms
March 30, 2023
Tickers
TEVA
Tags
TEVA
From MarketWatch
Is Big Pharma Coming For Your Cannabis Business?
March 27, 2023
From Benzinga
7 Strong Buy Stocks Under $10 to Snap Up Now
March 23, 2023
From InvestorPlace
3 No-Brainer Stocks to Buy With $10 Right Now
March 22, 2023
From Motley Fool
7 Core Stocks to Build a Solid Portfolio Around
March 13, 2023
From InvestorPlace
From Benzinga
Better Generics Pharmaceutical Stock: Teva or Viatris?
March 05, 2023
From Motley Fool
7 Smart Stock Picks for Cautious Investors
February 28, 2023
From InvestorPlace
Walmart, Home Depot And 3 Stocks To Watch Heading Into Tuesday
February 21, 2023
From Benzinga
From InvestorPlace
Teva Pharmaceutical Industries (TEVA) Q4 2022 Earnings Call Transcript
February 08, 2023
Tickers
TEVA
From Motley Fool
Teva Pharma Posts Lower Q4 Earnings, FY23 Outlook Within Expectations
February 08, 2023
Tickers
TEVA
From Benzinga
From Motley Fool
The 7 Best Growth Stocks to Buy for February 2023
February 06, 2023
From InvestorPlace
Down 30% in a Day, Is Catalyst Pharmaceuticals Doomed?
January 26, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.